[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4368 followers
Created: 2025-07-22 20:30:08 UTC

$IKNA Merger of Equals:

On July 22, 2025, Ikena Oncology, Inc. announced a special dividend of one contingent value right (CVR) for each outstanding share, applicable to stockholders as of July 24, 2025, in relation to a merger with Inmagene Biopharmaceuticals. This special dividend allows CVR holders to potentially receive net proceeds from certain asset agreements, contingent on specific payments being made after the merger's closing.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947756068463165833/c:line.svg)

**Related Topics**
[holders](/topic/holders)
[dividend](/topic/dividend)
[corporate finance](/topic/corporate-finance)
[$ikna](/topic/$ikna)

[Post Link](https://x.com/USCorpFilings/status/1947756068463165833)